Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial
ROCKVILLE, Md. & EDMONTON, Alberta, September 05, 2024--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) announced today that the first participant has been dosed ...